In-Vitro Colorectal Cancer Screening Tests Market to Reach US $980.6 Mn by 2023 End, Popularity of Non-Invasive Diagnostics Imparts Growth Momentum
The global in-vitro colorectal cancer screening tests market features an increasingly consolidated landscape with low threat of entry by new players, notes Transparency Market Research (TMR). A sizeable share of the global in-vitro colorectal cancer screening tests market has been contributed by only three companies in recent years. These leading companies-Beckman Coulter, Inc., Quest Diagnostics, Inc., and Sysmex Corporation-strive to retain their stronghold in the global in-vitro colorectal cancer screening tests market by engaging into long-term tie-ups and making several...
View full press release